Stockscreener 앱 받기
49.62
0.20%
-0.10
전일 마감가:
$49.72
열려 있는:
$49.35
하루 거래량:
2.37M
Relative Volume:
1.62
시가총액:
$6.77B
수익:
$550.17M
순이익/손실:
$201.35M
주가수익비율:
49.62
EPS:
1
순현금흐름:
$232.07M
1주 성능:
-8.60%
1개월 성능:
-25.97%
6개월 성능:
-16.61%
1년 성능:
-4.65%
1일 변동 폭
$49.01
$50.62
1주일 범위
$49.01
$55.96
52주 변동 폭
$47.66
$85.21
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
DOCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
49.62 | 9.36B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
293.36 | 47.81B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
68.48 | 12.09B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.77 | 8.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.32 | 6.84B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
Bank of Montreal Can Sells 49,807 Shares of Doximity, Inc. $DOCS - MarketBeat
Will Doximity Inc. Class stock maintain strong growthWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - newser.com
Will Doximity Inc. stock recover faster than marketShort Setup & Technical Analysis for Trade Confirmation - newser.com
Morgan Stanley Stays Neutral on Doximity, Highlights Strength in Video Module Business - Finviz
Will Doximity Inc. Class stock outperform benchmarksJuly 2025 Recap & Daily Price Action Insights - newser.com
Is Doximity Inc. stock overvalued by current metricsPortfolio Gains Report & Weekly Stock Performance Updates - newser.com
Why Doximity Inc. Class stock could outperform next year2025 Top Gainers & High Accuracy Swing Trade Signals - newser.com
How risky is Doximity Inc. Class stock compared to peersJuly 2025 Price Swings & Community Trade Idea Sharing Platform - newser.com
Campbell & CO Investment Adviser LLC Buys Shares of 14,480 Doximity, Inc. $DOCS - MarketBeat
Doximity (NYSE:DOCS) NYSE Composite Tracks Digital Care - Kalkine Media
Can Doximity Inc. Class stock deliver strong annual returnsNew Guidance & Low Risk Entry Point Tips - newser.com
Will Doximity Inc. Class stock benefit from mergersJuly 2025 Update & Accurate Intraday Trading Signals - newser.com
Will a bounce in Doximity Inc. offer an exitInflation Watch & Weekly Top Stock Performers List - newser.com
Real time social sentiment graph for Doximity Inc.Market Activity Report & Technical Pattern Based Signals - newser.com
Doximity (NASDAQ:DOCS) Now Covered by Analysts at BMO Capital Markets - MarketBeat
Jim Cramer Says Doximity is "Still Too Expensive" - Finviz
Jim Cramer Says Doximity is “Still Too Expensive” - MSN
Why Doximity Inc. stock is a value investor pickWeekly Loss Report & Weekly High Return Opportunities - Fundação Cultural do Pará
Is Doximity Inc. Class stock a top hedge fund pick2025 Sector Review & Smart Money Movement Tracker - Fundação Cultural do Pará
Is Doximity Inc. Class stock positioned for secular growth2025 Major Catalysts & Risk Adjusted Swing Trade Ideas - Fundação Cultural do Pará
Doximity, Inc. $DOCS Shares Sold by SBI Securities Co. Ltd. - MarketBeat
Doximity, Inc. (NYSE:DOCS) May Have Run Too Fast Too Soon With Recent 26% Price Plummet - simplywall.st
Is Doximity Inc. stock a buy on dipsJuly 2025 Outlook & Technical Pattern Based Buy Signals - newser.com
5 Must-Read Analyst Questions From Doximity's Q3 Earnings Call - Finviz
Jim Cramer: Don't Buy This Health Care Stock Yet, It Is 'Still Too Expensive' - Benzinga
BMO Capital Initiates Coverage on Doximity With Market Perform Rating, $55 Price Target - MarketScreener
BMO Capital Initiates Coverage of Doximity (DOCS) with Market Perform Recommendation - Nasdaq
5 Must-Read Analyst Questions From Doximity’s Q3 Earnings Call - The Globe and Mail
Doximity (DOCS) Receives New Market Perform Rating from BMO Capi - GuruFocus
Doximity, Inc. (DOCS) Stock forecasts - Yahoo Finance UK
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
Why Doximity (DOCS) is a Top Growth Stock for the Long-Term - sharewise.com
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.79%
자본화:
|
볼륨(24시간):